Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphoma
Jacky Y. K. Ho(University of Ottawa), David Allan(University of Ottawa), Antonio Giulivi(Health Canada), Isabelle Bence‐Bruckler(University of Ottawa), Harold Atkins(University of Ottawa), Sheryl McDiarmid(Ottawa Hospital), Mitchell Sabloff(University of Ottawa), Lothar Huebsch(University of Ottawa), Michael Halpenny(Canadian Blood Services), Lin Yang(Alberta Health Services), Behnam Banihashemi(University of Ottawa), Lisa Martin(Canadian Blood Services)
Cited by 34
Related Papers
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
|Journal of Computer Assisted Tomography|1980|503
Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [ <sup>18</sup> F]Fluorodeoxyglucose and [ <sup>11</sup> C]Deoxyglucose
|Journal of Cerebral Blood Flow & Metabolism|1985|419